Drugs / beta-epoietin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01450878 | Dec 2011 → Mar 2013 | ischemic disease | University Hospital, Limoges | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | béta-epoiétin | “The aim of this prospective randomized double blind study is to assess the effect of 100 000 UI of béta-epoiétin on kidney graft function, given to the deceased donor one hour...” NCT01450878 ↗ |
| Route | Intravenous | “intravenous 1000 000UI beta-epoietin one hour before organe retrieval” NCT01450878 ↗ |